BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6311653)

  • 1. Functional and morphologic characterization of human insulinomas.
    Berger M; Bordi C; Cüppers HJ; Berchtold P; Gries FA; Münterfering H; Sailer R; Zimmermann H; Orci L
    Diabetes; 1983 Oct; 32(10):921-31. PubMed ID: 6311653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations.
    Tomita T; Kimmel JR; Friesen SR; Doull V; Pollock HG
    Cancer; 1985 Oct; 56(7):1649-57. PubMed ID: 2992743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topographic abnormalities of proinsulin to insulin conversion in functioning human insulinomas. Comparison of immunoelectron microscopic and clinical data.
    Roth J; Komminoth P; Heitz PU
    Am J Pathol; 1995 Aug; 147(2):489-502. PubMed ID: 7639339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance.
    Creutzfeldt W; Arnold R; Creutzfeldt C; Deuticke U; Frerichs H; Track NS
    Diabetologia; 1973 Jun; 9(3):217-31. PubMed ID: 4351967
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution patterns of proinsulin and insulin in human insulinomas: an immunohistochemical analysis in 76 tumors.
    Roth J; Klöppel G; Madsen OD; Storch MJ; Heitz PU
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 63(1):51-61. PubMed ID: 1362022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fuel-induced insulin release in vitro from insulinomas transplanted into the rat kidney.
    Hoenig M; Ferguson DC; Matschinsky FM
    Diabetes; 1984 Jan; 33(1):1-7. PubMed ID: 6140199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties.
    Wiesli P; Schmid C; Perren A; Pfammatter T; Spinas GA; Keller U
    J Endocrinol Invest; 2004 Oct; 27(9):832-8. PubMed ID: 15648547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histology, ultrastructure, and tissue culture of human insulinomas.
    Akagi T; Fujii Y
    Cancer; 1981 Jan; 47(2):417-24. PubMed ID: 6257377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of proinsulin and insulin in human insulinoma: preliminary immunohistochemical results.
    Roth J; Kasper M; Stamm B; Häcki WH; Storch MJ; Madsen OD; Klöppel G; Heitz PU
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):287-92. PubMed ID: 2565624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinoma. An immunocytochemical and morphologic analysis of 95 cases.
    Liu TH; Tseng HC; Zhu Y; Zhong SX; Chen J; Cui QC
    Cancer; 1985 Sep; 56(6):1420-9. PubMed ID: 2992737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative abnormality of insulin secretion in a case with insulinoma.
    Harano Y; Kohama M; Araki N; Sakamoto A; Hoshi M
    Endocrinol Jpn; 1975 Apr; 22(2):175-80. PubMed ID: 168060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocrine pancreas in patients with insulinomas. An immunocytochemical and ultrastructural study of the nontumoral tissue with morphometrical evaluations.
    Bani Sacchi T; Bani D; Biliotti G
    Int J Pancreatol; 1989 Jul; 5(1):11-28. PubMed ID: 2568382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron microscope localisation of insulin-like immunoreactivity of conventionally processed human insulinomas.
    Berger G; Berger F; Dutrieux N; Guillaud MH; Vauzelle JL
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(5):443-50. PubMed ID: 2833834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective regulation of insulin secretion in diabetes and insulinoma.
    Flatt PR
    Biochem Soc Trans; 1990 Feb; 18(1):124-7. PubMed ID: 2158914
    [No Abstract]   [Full Text] [Related]  

  • 15. Proinsulin-like component of circulating insulin in the basal state and in patients and hamsters with islet cell tumors.
    Gorden P; Sherman B; Roth J
    J Clin Invest; 1971 Oct; 50(10):2113-22. PubMed ID: 4330005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.
    Hayashi M; Floyd JC; Pek S; Fajans SS
    J Clin Endocrinol Metab; 1977 Apr; 44(4):681-94. PubMed ID: 14970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic insulinoma with long survival and glucagonoma syndrome.
    D'Arcangues CM; Awoke S; Lawrence GD
    Ann Intern Med; 1984 Feb; 100(2):233-5. PubMed ID: 6318634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal analysis of insulin and somatostatin secretion and L-dopa decarboxylase expression by a rat islet cell tumor.
    Oie HK; Gazdar AF; Minna JD; Weir GC; Baylin SB
    Endocrinology; 1983 Mar; 112(3):1070-5. PubMed ID: 6129963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staining reactions in an islet cell carcinoma of - 2 -type.
    Grimelius L; Petersson B; Lundquist G; Dahlgren S; Parrow A
    Acta Soc Med Ups; 1971; 76(1-2):49-57. PubMed ID: 4109135
    [No Abstract]   [Full Text] [Related]  

  • 20. Human Insulinomas Show Distinct Patterns of Insulin Secretion In Vitro.
    Henquin JC; Nenquin M; Guiot Y; Rahier J; Sempoux C
    Diabetes; 2015 Oct; 64(10):3543-53. PubMed ID: 26116696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.